Abstract
The effect of the intrauterine contraceptive device (IUD) on the composition of endometrial secretion has been studied using the monoclonal antibody D9B1. The antibody binds to a polypeptide-associated oligosaccharide epitope that is secreted by endometrial epithelium in the secretory phase with a maximum around the time of implantation. In endometria affected by the IUD in situ, a significant reduction in epitope expression has been observed using immunohistochemistry. This defect can occur against a background of normal secretory differentiation and in the expectation of normal ovarian stimulus. The data provide new insight into the contraceptive mechanisms of action of the IUD. © 1989.
Original language | English |
---|---|
Pages (from-to) | 81-89 |
Number of pages | 8 |
Journal | Contraception |
Volume | 40 |
Issue number | 1 |
Publication status | Published - Jul 1989 |